Address
Email address
Phone number
At NEXTCLINICS, we transform lives with advanced technology and highly specialised and holistic healthcare, delivered by medical experts.
Name
BioEximi OÜ
Registry code
11767227
VAT number
EE102211425
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.11.2009 (14)
Financial year
01.01-31.12
Capital
2 560.00 €
Activity
86909 - Other healthcare activities not classified elsewhere
1 601 558 €
-146 151 €
-9%
3 092 €
(estimate is approximate)
-144 676 €
13
Submitted
No tax arrears
101%
-29%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
NEXTCLINICS Estonia OÜ 14674334 | 100% - 2 560.00 EUR | - | - | |
Soile Moorats 24.09.1979 (45) | - | Procurator | - | |
Karin Rosenstein 04.03.1981 (43) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
Jüri Laasik 13.10.1956 (68) | - | - | - | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Reproductive Management OÜ 12171356 | - | - | - | Founder |
2019 26.05.2020 | 2020 30.06.2021 | 2021 30.06.2022 | 2022 21.06.2023 | 2023 28.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 619 909 € | 683 161 € | 1 054 278 € | 1 255 148 € | 1 601 558 € |
Net profit (loss) for the period | 223 560 € | 30 099 € | -121 422 € | -237 246 € | -146 151 € |
Profit Margin | 36% | 4% | -12% | -19% | -9% |
Current Assets | 829 080 € | 1 012 731 € | 169 103 € | 260 283 € | 337 615 € |
Fixed Assets | 0 € | 93 674 € | 207 299 € | 202 191 € | 158 185 € |
Total Assets | 829 080 € | 1 106 405 € | 376 402 € | 462 474 € | 495 800 € |
Current Liabilities | 71 980 € | 265 024 € | 579 934 € | 388 553 € | 516 152 € |
Non Current Liabilities | 0 € | 54 182 € | 38 747 € | 128 446 € | 124 324 € |
Total Liabilities | - | 319 206 € | 618 681 € | 516 999 € | 640 476 € |
Share Capital | - | - | - | - | - |
Equity | 757 100 € | 787 199 € | -242 279 € | -54 525 € | -144 676 € |
Employees | 13 | 11 | 13 | 13 | 13 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 49 174.93 € | 86 147.12 € | 80 730.86 € | 31 |
2023 Q4 | 33 296.83 € | 67 616.27 € | 65 064.16 € | 32 |
2023 Q3 | 29 986.58 € | 69 903.47 € | 68 038.74 € | 29 |
2023 Q2 | 52 197.26 € | 84 069.67 € | 79 158.09 € | 27 |
2023 Q1 | 42 113.47 € | 70 885.72 € | 66 009.01 € | 29 |
2022 Q4 | 22 970.86 € | 60 081.54 € | 58 804.98 € | 29 |
2022 Q3 | 22 896.28 € | 59 619.89 € | 58 281.29 € | 27 |
2022 Q2 | 61 851.37 € | 58 531.22 € | 49 146.82 € | 27 |
2022 Q1 | 6 690.43 € | 47 671.33 € | 48 798.34 € | 26 |
2021 Q4 | 37 079.95 € | 49 620.59 € | 45 085.86 € | 29 |
2021 Q3 | 24 787.53 € | 40 694.39 € | 38 496.69 € | 32 |
2021 Q2 | 19 500.76 € | 40 256.34 € | 39 072.22 € | 30 |
2021 Q1 | 16 804.69 € | 48 643.84 € | 36 779.09 € | 30 |
2020 Q4 | 16 026.67 € | 38 176.74 € | 37 367.21 € | 24 |
2020 Q3 | 4 226.55 € | 31 159.43 € | 32 070.34 € | 23 |
2020 Q2 | 194.16 € | 14 340.99 € | 15 915.71 € | 21 |
2020 Q1 | 12 209 € | 19 570.75 € | 21 167.94 € | 20 |